BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 23513788)

  • 1. [Epidemiology, natural history, and risk factors of hepatocellular carcinoma].
    Fares N; Péron JM
    Rev Prat; 2013 Feb; 63(2):216-7, 220-2. PubMed ID: 23513788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural history of hepatocellular carcinoma and current treatment options.
    Raoul JL
    Semin Nucl Med; 2008 Mar; 38(2):S13-8. PubMed ID: 18243838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hepatocellular carcinoma--epidemiology and treatment].
    Małkowski P; Pacholczyk M; Łagiewska B; Adadyński L; Wasiak D; Kwiatkowski A; Chmura A; Czerwiński J
    Przegl Epidemiol; 2006; 60(4):731-40. PubMed ID: 17682755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Epidemiology, natural history and pathogenesis of hepatocellular carcinoma].
    Maillard E
    Cancer Radiother; 2011 Feb; 15(1):3-6. PubMed ID: 21239205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology and natural history of hepatocellular carcinoma.
    McGlynn KA; London WT
    Best Pract Res Clin Gastroenterol; 2005 Feb; 19(1):3-23. PubMed ID: 15757802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma.
    Kew MC
    Pathol Biol (Paris); 2010 Aug; 58(4):273-7. PubMed ID: 20378277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Management of hepatocellular carcinoma].
    Pache I; Bize P; Halkic N; Montemurro M; Giostra E; Majno P; Moradpour D
    Rev Med Suisse; 2010 Jan; 6(233):198-202. PubMed ID: 20214192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic hepatitis B and hepatocellular carcinoma.
    McClune AC; Tong MJ
    Clin Liver Dis; 2010 Aug; 14(3):461-76. PubMed ID: 20638025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements.
    Asia-Pacific Working Party on Prevention of Hepatocellular Carcinoma
    J Gastroenterol Hepatol; 2010 Apr; 25(4):657-63. PubMed ID: 20492323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors that affect risk for hepatocellular carcinoma and effects of surveillance.
    Yang JD; Harmsen WS; Slettedahl SW; Chaiteerakij R; Enders FT; Therneau TM; Orsini L; Kim WR; Roberts LR
    Clin Gastroenterol Hepatol; 2011 Jul; 9(7):617-23.e1. PubMed ID: 21459158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for hepatocellular carcinoma in patients with liver cirrhosis.
    Macías Rodríguez MA; Rendón Unceta P; Tejada Cabrera M; Infante Hernández JM; Correro Aguilar F; Díaz García F; Benítez Rodríguez E; Mangas Rojas A; Martín Herrera L
    Rev Esp Enferm Dig; 2000 Jul; 92(7):458-69. PubMed ID: 11026763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced HCC: emerging molecular therapies.
    Finn RS
    Minerva Gastroenterol Dietol; 2012 Mar; 58(1):25-34. PubMed ID: 22419002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular carcinoma.
    Desjardins LA
    Clin J Oncol Nurs; 2002; 6(2):107-8. PubMed ID: 11889672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH.
    Salomao M; Yu WM; Brown RS; Emond JC; Lefkowitch JH
    Am J Surg Pathol; 2010 Nov; 34(11):1630-6. PubMed ID: 20975341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NASH and HCC.
    Page JM; Harrison SA
    Clin Liver Dis; 2009 Nov; 13(4):631-47. PubMed ID: 19818310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HBV-related HCC, clinical issues and therapy.
    Iavarone M; Colombo M
    Dig Liver Dis; 2011 Jan; 43 Suppl 1():S32-9. PubMed ID: 21195370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus infection and hepatocellular carcinoma.
    Blonski W; Reddy KR
    Clin Liver Dis; 2008 Aug; 12(3):661-74, x. PubMed ID: 18625433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of hepatocellular carcinoma.
    Bosch FX; Ribes J; Cléries R; Díaz M
    Clin Liver Dis; 2005 May; 9(2):191-211, v. PubMed ID: 15831268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocellular carcinoma in western Sydney. Aetiology, changes in incidence, and opportunities for better outcomes.
    Brotodihardjo AE; Tait N; Weltman MD; Liddle C; Little JM; Farrell GC
    Med J Aust; 1994 Oct; 161(7):433-5. PubMed ID: 7935098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocarcinogenesis.
    Lau JY; Lai CL
    Trop Gastroenterol; 1990; 11(1):9-24. PubMed ID: 2162576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.